-
Mashup Score: 1300 people to benefit from new treatment for advanced breast cancer recommended by NICE following price deal - 4 month(s) ago
The recommendation reverses NICE’s earlier draft decision not to recommend talazoparib for adults with BRCA 1 or 2 mutated HER2-negative locally advanced or metastatic breast cancer after prior chemotherapy. It follows the offer of an increased discount to the price of talazoparib, also called Talzenna, by the company (Pfizer). Once the draft guidance becomes final next month it will mean NICE will have made positive recommendations in all 20 of its completed appraisals of breast cancer treatments since
Source: www.nice.org.ukCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 37
In monarchE, abemaciclib improved 2-year and 4-year invasive disease-free survival (IDFS), and in NATALEE, ribociclib improved 3-year IDFS; overall survival analyses for both trials remain immature. Thus, both abemaciclib and ribociclib are reasonable options in the adjuvant setting to reduce IDFS risk.
Source: dailynews.ascopubs.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @DrSGraff: Considering Adjuvant CDK4/6 Inhibitors?: monarchE and NATALEE in Clinical Practice https://t.co/ZKomXSH3gx #bcsm @ASCO https:…
-
-
Mashup Score: 0Surgeons carrying out operations just once a fortnight - 1 year(s) ago
Staff shortages and lack of theatres mean planned procedures have fallen amid huge NHS backlogs, says leading medic
Source: The TelegraphCategories: Hem/Oncs, Latest HeadlinesTweet-
https://t.co/ZmPcxCIFli
-
-
Mashup Score: 1Breast cancer drug approved for NHS after maker agrees discount - 3 year(s) ago
Reversal of earlier rejection by Nice of abemaciclib – known as Verzenios – is welcomed by campaigners
Source: the GuardianCategories: Latest Headlines, Oncologists1Tweet-
Breast cancer drug approved for NHS after maker agrees discount | Breast cancer | The Guardian https://t.co/lD3C3uBxVZ
-
-
Mashup Score: 4London Marathon 2021 - 3 year(s) ago
Help Harry change the world! Make a donation now
Source: uk.virginmoneygiving.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Please sponsor my friend and colleague Richard Slade’s son, Harry, who is running the London Marathon 2021 for The Christie Charity: @ucharityrs @TheChristie - https://t.co/1g0oNzKn53
-
-
Mashup Score: 203Will COVID become a disease of the young? - 3 year(s) ago
A growing share of infections among unvaccinated youths in countries with high vaccination rates is putting the spotlight on the role of young people in the pandemic.
Source: www.nature.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @EricTopol: The shift of Covid to an illness predominant in the young https://t.co/SoHrloUSwQ @Nature by @SmritiMallapaty https://t.co/S…
-
-
Mashup Score: 0
India’s coronavirus crisis is the worst since the pandemic began, and it will… Sohel Modi needs your support for Support for Covid victims & families in India
Source: gofundme.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Support for Covid victims & families in India https://t.co/vbB5NVGFNA
-
-
Mashup Score: 0Inside the Delhi hospital at breaking point - 3 year(s) ago
Covid-19 patients who get a hospital bed are being described as the lucky ones in India’s deadly second wave.
Source: BBC NewsCategories: Hem/Oncs, Latest HeadlinesTweet-
India Covid crisis: Inside the Delhi hospital running low on beds and oxygen https://t.co/NpK6fOQyor
-
-
Mashup Score: 2India Covid crisis: Hospitals buckle under record surge - 3 year(s) ago
Families of Covid patients are pleading for hospital care as emergency rooms and wards overflow.
Source: BBC NewsCategories: Hem/Oncs, Latest HeadlinesTweet-
Heartbreaking: India Covid crisis: Hospitals buckle under record surge https://t.co/RxC4cE8xFK
-
300 people to benefit from new treatment for advanced breast cancer recommended by NICE following price deal@- this is great news. In my anecdotal experience Talazoparib is an excellent drug with few side effects. https://t.co/owUNqjzaxK